Home > Journals > Panminerva Medica > Past Issues > Panminerva Medica 2015 September;57(3) > Panminerva Medica 2015 September;57(3):109-13

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints
Cite this article as

PANMINERVA MEDICA

A Journal on Internal Medicine


Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,698


eTOC

 

ORIGINAL ARTICLES  


Panminerva Medica 2015 September;57(3):109-13

Copyright © 2015 EDIZIONI MINERVA MEDICA

language: English

Efficacy of the low-dose Saccharum iron treatment of idiopathic restless legs syndrome

Zhang X., Chen W. W., Huang W. J.

Department of Neurology, Xuzhou Central Hospital, Xuzhou, Jiangsu Province, China


PDF  


AIM: The aim of the study was to determine the efficacy of low-dose and high-dose Saccharum iron injected intravenously in patients with idiopathic restless legs syndrome (RLS) by detecting levels of serum ferritin (SF) and international RLS Severity Scale.
METHODS: For this purpose, 38 patients with idiopathic RLS were randomly divided into the following two groups: low-dose group (18 cases) and high-dose group (20 cases). Low-dose group received Saccharum iron intravenously (200 mg/dose); once a week for 5 weeks with a total dose of 1000 mg. High-dose group received Saccharum iron intravenously (500 mg/dose); once every two weeks for 4 weeks with a total dose of 1000 mg. The pre- and post-treatment (at 2, 4, and 6 weeks) level of SF and RLS scores were determined and the differences were compared between two groups.
RESULTS: Post-therapeutic SF levels increased significantly in both groups as compared with before treatment (P<0.05). At 6-week post-therapy, SF levels in low-dose group were significantly higher than those in high-dose group (P<0.05). The clinical symptoms were improved and RLS scores were lower than pretreatment ratings in both groups (P<0.05). After 6 weeks of treatment, RLS scores of low-dose group were lower than those of high-dose group (P<0.05).
CONCLUSION: Both the low-dose and high-dose Saccharum iron treatments increased the SF levels and improved clinical symptoms in patients with idiopathic RLS; however, the low-dose iron treatment was found to be more effective and had fewer side effects.

top of page

Publication History

Cite this article as

Zhang X, Chen WW, Huang WJ. Efficacy of the low-dose Saccharum iron treatment of idiopathic restless legs syndrome. Panminerva Med 2015 September;57(3):109-13. 

Corresponding author e-mail

baogaozx@163.com